Avaxim | The Australian Immunisation Handbook

Date printed: 12/12/2018

Sponsor:

Sanofi-Aventis Australia

Administration route:

Intramuscular injection

Vaccine group:

Monovalent vaccines

Registered for use in people aged ≥2 years.

Each 0.5 mL monodose pre-filled syringe contains:

160 antigen units of inactivated hepatitis A virus (GBM strain)
0.3 mg aluminium as aluminium hydroxide
2.5 µL phenoxyethanol
12.5 µg formaldehyde
≤2.5 µg neomycin
<50 ng bovine serum albumin
traces of polysorbate 80

The product information and consumer medicine information for Avaxim have more details.

Audience:

Infants and children

Page history

Last updated:

4 June 2018

Last reviewed:

4 June 2018

Is there anything wrong with this page?

This document was printed on: 14/12/2018. Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/avaxim.